Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pathogens11111259
PubMed Identifier: 36365010
Publication URI: http://europepmc.org/abstract/MED/36365010
Type: Journal Article/Review
Volume: 11
Parent Publication: Pathogens (Basel, Switzerland)
Issue: 11
ISSN: 2076-0817